This information is disseminated under the sponsorship of the U.S. Department of Transportation
in the interest of information exchange.
The United States Government assumes no Liability for the contents or use thereof.
Carisoprodol |
| Description |
SOMAŽ carisoprodol is indicated for the relief of acute, painful musculoskeletal conditions. Carisoprodol is metabolized to meprobamate a CDS. |
| Therapeutic Low |
4.0000 |
| Therapeutic High |
7.0000 |
| Units |
ug/mL |
| Specimen |
P |
| Half Life Low |
1.50 |
| Half Life High |
2.60 |
| VOD Low |
0.00 |
| VOD High |
0.00 |
| Toxic Level |
30.000 |
| Lethal Level |
110.000 |
| Plasma to Whole Blood ratio |
0.00 |
| Warnings |
Warnings - this drug may impair the mental and/or physical abilities required for the performance of potentially hazardous tasks such as driving a motor vehicle or operating machinery. |